Laursen, Henrik Vitus Bering http://orcid.org/0000-0002-6270-3364
Jørgensen, Emmelie Ploug
Vestergaard, Peter http://orcid.org/0000-0002-9046-2967
Ehlers, Lars Holger http://orcid.org/0000-0001-6512-5566
Article History
Accepted: 19 March 2023
First Online: 6 July 2023
Declarations
:
: This article is based on previous studies and does not involve any new studies of human or animal subjects performed by the authors.
: This study was supported by Boehringer Ingelheim, who had no role in the design, analysis, or interpretation of the results in this study. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as it relates to Boehringer Ingelheim’s substances and intellectual property considerations.
: Peter Vestergaard is the head of research at Steno Diabetes Center North Denmark, funded by the Novo Nordisk Foundation. Lars Holger Ehlers has received funding for research and compensation for lecture activities from Boehringer Ingelheim. Henrik Vitus Bering Laursen has received partial funding for his PhD from Steno Diabetes Center North Denmark, which in turn is funded by the Novo Nordisk Foundation, and additional funding from Boehringer Ingelheim. Emmelie Ploug Jørgensen declares that she has no conflicts of interest.
: HVBL was responsible for the conception of the study question and the search strategy, along with collecting, storing, and analysing data, writing the manuscript, and screening the included studies. EPJ contributed to the screening of studies, collecting data, writing and commenting on the manuscript, and providing interpretations of the results. LHE and PV provided ideas for the conception of the study question, generated ideas regarding focus areas of the analysis, provided comments and corrections to the manuscript, and provided feedback throughout the writing period. All authors read and approved the final manuscript.
: The data collected and generated from the included studies can be sent upon request to the corresponding author.